Pregled bibliografske jedinice broj: 1260056
High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study
High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study // Acta Diabetologica, 56 (2019), 9; 1045-1049 doi:10.1007/s00592-019-01346-1 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1260056 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
High level of clinical inertia in insulin
initiation in type 2 diabetes across Central and
South-Eastern Europe: insights from SITIP study
Autori
Campbell, Matthew D. ; Babic, Drazen ; Bolcina, Uros ; Smirčić-Duvnjak, Lea ; Tankova, Tsvetalina ; Mitrakou, Asimina ; Kempler, Peter ; Janez, Andrej
Izvornik
Acta Diabetologica (0940-5429) 56
(2019), 9;
1045-1049
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Clinical inertia ; Insulin therapy initiation ; Type 2 diabetes mellitus.
Sažetak
Aims: Little is known regarding initiation of insulin therapy in type 2 diabetes (T2D) in Central and South-Eastern European countries. Therefore, we conducted a survey to characterise the prescribing practices of specialist diabetes healthcare professionals in this region and assessed factors that influence clinical decision- making regarding insulin initiation in T2D. Methods: A cross-sectional survey sampled 211 specialist diabetes healthcare prescribers from five Central and South-Eastern European countries (Bulgaria, Croatia, Greece, Hungary, and Slovenia). A structured questionnaire was developed which surveyed current clinical practices and influencing factors, barriers to insulin initiation, and combination therapy prescribing preferences. Result: Only 9.4% (20 of out of 211 respondents) of healthcare professionals would initiate insulin therapy in T2D patients at the recommended HbA1c threshold of 7-7.9% [53-63 mmol/mol]. Large regional differences were evident in insulin initiation thresholds (≥ 9.0% [≥ 75 mmol/mol]: Bulgaria 80.8% vs. Slovenia 13.3%). Psychological distress was recorded as the major barrier to insulin initiation. Health insurance regulations were ranked more important than personal clinical experience and clinical guidelines in clinical decision-making. Information from peers was more influential than manufacturer information, clinical experience, and continuous medical education, respectively, for insulin initiation. Conclusions: Despite large regional variation, there is widespread delay of insulin initiation from specialist diabetes healthcare professionals in Central and South-Eastern Europe.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE